Job, patent and robot

> While recent advances in nanotech hold promise for targeted drug delivery, there is still work to be done in making sure all nanoparticles reach tumors in a uniform way. It's a problem that needs to be overcome if nano-enabled drug delivery is to reach its full potential. Massachusetts researchers discuss how to overcome these barriers. Abstract

Drug delivery job of the week: Vice president, project management, Ekteino Laboratories, Boston—a startup, drug delivery-based research company that is working with a unique technology licensed from a leading university. Job listing

> Drug delivery patent application of the week: Delivery of Oligonucleotide-Functionalized Nanoparticles. More

> Drug delivery robot of the week: MKR-003 Robot

Suggested Articles

Purdue's reformulated OxyContin may stop patients from snorting or injecting the drug, but it doesn't curb abuse overall, an FDA panel determined.

Roche is gearing up to launch an eye implant to make its Lucentis AMD drug easier to use. But the drugmaker has even bigger plans for the device.

Delivery specialist IntelGenx struck two deals to develop oral films for prescription psychedelics this summer with Canada's Cybin and ATAI.